Showing results (91-100 of 157) with videos related to
Sort By:
Pageof 16
Clinical Drug Investigation|February 16, 2026
Characterization of the Safety Profile of the Triple Monoamine Reuptake Inhibitor Dasotraline Based on Clinical Trial Data and Disproportionality Analyses of Four Related Pharmacological Classes Using Real-World Data from the FDA Adverse Event Reporting SystemSolomiya Gumenyuk, Ajay Ogirala, Steven T Szabo, et al.BMC Geriatrics|January 11, 2023
Impact of dementia care training on nurse care managers' interactions with family caregiversTaylor J Mellinger, Brent P Forester, Christine Vogeli, et al.Behavioural Brain Research|May 17, 2011
Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapineKamal S Bhatia, Steven T Szabo, J Corey Fowler, et al.Bioorganic & Medicinal Chemistry|June 27, 2001
N-(3-acyloxy-2-benzylpropyl)-N'-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligandsJ Lee, J Lee, T Szabo, et al.Journal of Clinical Psychopharmacology|November 6, 2019
Updates on Preclinical and Translational Neuroscience of Mood Disorders: A Brief Historical Focus on Ketamine for the ClinicianNicholas A Mischel, Michael D Kritzer, Ashwin A Patkar, et al.Sleep Medicine|May 20, 2023
A multicenter, double-blind, placebo-controlled, randomized, Phase 1b crossover trial comparing two doses of ulotaront with placebo in the treatment of narcolepsy-cataplexySteven T Szabo, Seth C Hopkins, Robert Lew, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 8, 2001
Functional analysis of capsaicin receptor (vanilloid receptor subtype 1) multimerization and agonist responsiveness using a dominant negative mutationE V Kuzhikandathil, H Wang, T Szabo, et al.Journal of the American Chemical Society|November 22, 2001
"Flexiball" toolkit: a modular approach to self-assembling capsulesB M O'Leary, T Szabo, N Svenstrup, et al.Neurology|May 25, 2005
Patients with ALS can use sensorimotor rhythms to operate a brain-computer interfaceA Kübler, F Nijboer, J Mellinger, et al.Psychiatry Research|August 16, 2024
Enrichment using speech latencies improves treatment effect size in a clinical trial of bipolar depressionJoshua S Siegel, Alex S Cohen, Steven T Szabo, et al.Pageof 16